semaglutide cardiovascular risk Oral and Outcomes in Type 2 Diabetes Oral Semaglutide and Cardiovascular Outcomes

The composition of gut microbiota plays a crucial role in host health, with dietary nutritional characteristics significantly influencing the regulation, maintenance, and proliferation of beneficial microorganisms

doi: 10.1021/acschembio.2c00735

Inflammatory bowel disease (IBD) patients, including those with Crohn's disease or ulcerative colitis, require careful evaluation before GLP-1 use

No additional side effects were identified

Effects of oral L-carnitine supplementation on insulin sensitivity indices in response to glucose feeding in lean and overweight/obese males

We ask whether a cognitive-computational index of motivationreliably linked to neuropsychiatric symptomsis altered in the context of type-2 diabetes and treatment with a GLP-1 agonist (semaglutide)